The global pollen allergy market is now estimated at US$ 5850.8 million in 2023 and is expected to grow at a 4.2% CAGR. Because to technology advancements in healthcare, the market is expected to reach US$ 8828.6 million by 2033.The rise in the number of people suffering from pollen-based allergies, including hay fe.
ROCKVILLE, Md. (BUSINESS WIRE) #celltherapy Immunomic Therapeutics, Inc., (“ITI”), a privately-held clinical-stage biotechnology company pioneering the study of LAMP-mediated nucleic acid-based immunotherapy announced today that it will present at the Supply Chain and Logistics for Cell Therapy Summit, March 7-9.
/PRNewswire/ In-depth analysis provided in the report includes: Current and future market trends to highlight market conditions Comparative analysis of the.
The prevalence of gastric cancer has been rising since the past few years, which prompts the growing demand for treatment options. The increasing prevalence of cancer, the robust pipeline,